Copyright
©The Author(s) 2022.
World J Meta-Anal. Jun 28, 2022; 10(3): 186-194
Published online Jun 28, 2022. doi: 10.13105/wjma.v10.i3.186
Published online Jun 28, 2022. doi: 10.13105/wjma.v10.i3.186
Figure 1 Flow diagram of articles with hepatitis B virus infected patients.
HBV: Hepatitis B virus.
Figure 2 Flow diagram of articles with hepatitis C virus infected patients.
HCV: Hepatitis C virus; DAA: Direct acting antivirals.
Figure 3 In hepatitis B virus patients, a non-inflammatory state (serum alanine aminotransferase levels were within normal range) were set as 1.
Hazard ratios of patients in an inflammatory state (serum alanine aminotransferase levels above normal range) were calculated.
Figure 4 In hepatitis C virus patients, Hazard ratios of patients in a non-inflammatory state (serum alanine aminotransferase levels were within normal range) were set as 1.
Hazard ratios of patients in an inflammatory state (serum alanine aminotransferase levels above normal range) were calculated.
- Citation: Tarao K, Nozaki A, Komatsu H, Ideno N, Komatsu T, Ikeda T, Taguri M, Maeda S. Difference in incidence of developing hepatocellular carcinoma between hepatitis B virus-and hepatitis C virus-infected patients. World J Meta-Anal 2022; 10(3): 186-194
- URL: https://www.wjgnet.com/2308-3840/full/v10/i3/186.htm
- DOI: https://dx.doi.org/10.13105/wjma.v10.i3.186